Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1
Dhanya K. Nambiar(Stanford University), Rajesh Agarwal(University of Colorado Anschutz Medical Campus)
Cited by 62
Related Papers
A Novel Anticancer Agent, Decursin, Induces G1 Arrest and Apoptosis in Human Prostate Carcinoma Cells
|Cancer Research|2005|197
Galectin-1–driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance
|Journal of Clinical Investigation|2019|174
Effect of Silibinin on the Growth and Progression of Primary Lung Tumors in Mice
|JNCI Journal of the National Cancer Institute|2006|163